Baglietto-Vargas, D. et al. Nat. Commun. 12, 2421 (2021)
Most mouse models of Alzheimer’s disease (AD) consist of transgenic mice that overexpress human genes associated with familial AD, an early-onset form of the disease caused by rare and fully penetrant mutations in the genes APP, PSEN-1 and PSEN-2. The PD-APP transgenic mouse, which overexpresses human amyloid precursor protein (APP 717V→F), was the first APP-based model to reproduce amyloid β-peptide (Aβ) pathology in the form of amyloid plaques in mice; since then researchers have created and characterized more than 170 genetically modified mouse models containing AD-linked mutations.
Although these mice have provided valuable insights into disease mechanisms, early-onset AD accounts for less than 5% of AD cases and new mouse models that mimic the late-onset progression seen in sporadic human AD, the most common form of the disease, are needed.
In a new study published in Nature Communications, a team of investigators led by Frank M. LaFerla from University of California, Irvine generated a new mouse model in which they substituted the mouse Aβ peptide for its human counterpart (hAβ). The mice, which carry no familial AD mutation and develop age-dependent behavioral and phenotypic alterations, might represent an important step towards modeling late-onset AD.
The investigators used a knock-in (KI) strategy to humanize the murine App gene by changing 3 amino acids within the sequence of the Aβ peptide, a product of APP processing. In these mice, hAβ-KI allele is integrated in the App locus, under the control of endogenous gene-regulatory elements; therefore humanized App is expressed at murine physiological levels. “These results are significant because APP is not overexpressed in human sporadic AD, and the hAβ-KI mouse model recapitulates this salient feature,” explain the investigators in their report.
Detailed phenotypic characterization of the mice showed that substitution of mouse Aβ with the wild-type human isoform was sufficient to produce significant changes in cognition, synaptic plasticity, inflammation, OC+/PAS granule formation and gene expression in hAβ-KI mice. These changes were associated with an age-associated increase in insoluble Aβ and decrease in soluble Aβ in the brain of the mice. However, the investigators could not detect amyloid aggregates in hAβ-KI brains, which suggests that additional factors are required for the formation of amyloid plaques.
The investigators conclude that the hAβ-KI mouse line will be a useful platform to investigate the many genetic, aging, and environmental factors that drive the development of AD and lead to formation of plaques.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Bras, A. A new mouse model to study late-onset Alzheimer’s disease. Lab Anim 50, 151 (2021). https://doi.org/10.1038/s41684-021-00780-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-021-00780-5